(Q40376003)

20 September 2017

1 reference

title

Glucocorticoid resistance in asthma (English)

1 reference

glucocorticoid resistance

20 September 2017

0 references

1 reference

Barnes PJ

1

1 reference

20 September 2017

Greening AP

series ordinal

2

1 reference

20 September 2017

Crompton GK

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

American Journal of Respiratory and Critical Care Medicine

20 September 2017

published in

1 reference

20 September 2017

volume

152

1 reference

20 September 2017

issue

6 Pt 2

1 reference

20 September 2017

page(s)

S125-40

1 reference

Inhaled glucocorticoids for asthma

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

21 January 2018

Steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Steroid Resistance in Bronchial Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Anti-inflammatory actions of steroids: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

On observing patterns of airflow obstruction in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Cutaneous vasoconstrictor response to glucocorticoids in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

The steroid and thyroid hormone receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

The glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Functional domains of the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Multiple and cooperative trans-activation domains of the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Delineation of a small region within the major transactivation domain of the human glucocorticoid receptor that mediates transactivation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Gene regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

The glucocorticoid domain: steroid-mediated changes in the rate of synthesis of rat hepatoma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Transcriptional analyses of steroid-regulated gene networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Genes newly identified as regulated by glucocorticoids in murine thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Identification of mRNAs associated with programmed cell death in immature thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Regulatory crosstalk at composite response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

The AU-rich sequences in the 3' untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Interference of pathway specific transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Control of transcription factors by signal transduction pathways: the beginning of the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Allergen-induced oxygen radical release from bronchoalveolar lavage cells and airway hyperresponsiveness in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

New immunosuppressive drugs: mechanistic insights and potential therapeutic advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Contingent genetic regulatory events in T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Nitric oxide and lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Nitric oxide and asthmatic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Expression of inducible nitric oxide in human lung epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Leukotriene B4 stimulates c-fos and c-jun gene transcription and AP-1 binding activity in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Lipocortin-1: cellular mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Human calpactin II (lipocortin I) messenger ribonucleic acid is not induced by glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Glucocorticoids do not alter peptidase expression on a human bronchial epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Induction by Glucocorticoids of Angiotensin Converting Enzyme Production from Bovine Endothelial Cells in Culture and Rat Lung In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Effects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Regulation of Human Alveolar Macrophage- and Blood Monocyte-derived Interleukin-8 by Prostaglandin E2 and Dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Corticosteroid inhibition of airway microvascular leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Pharmacologic control of plasma exudation into tracheobronchial airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Increased nitric oxide in exhaled air of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Familial and iatrogenic cortisol receptor resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Spontaneous Hypercortisolism without Cushing's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Regulation of glucocorticoid receptor expression in cultured fibroblasts from a patient with familial glucocorticoid resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

A mutation of the glucocorticoid receptor in primary cortisol resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Genetic variation of the glucocorticoid receptor from a steroid-resistant primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Corticosteroid pharmacokinetics in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Steroid-resistant asthma: immunologic and pharmacologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Circulating autoantibodies to recombinant lipocortin-1 in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Differential in vitro regulation by glucocorticoids of monocyte-derived cytokine generation in glucocorticoid-resistant bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Effect of corticosteroid treatment on interleukin-1 and tumour necrosis factor secretion by monocytes from subjects with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

The stress-activated protein kinase subfamily of c-Jun kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Cytokines. 3. Cytokines in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Questions about inhaled beta 2-adrenoceptor agonists in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

The use of beta-agonists and the risk of death and near death from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Regular inhaled beta-agonist treatment in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Theophylline in the management of asthma: time for reappraisal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Corticosteroid sparing agents in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Triamcinolone in corticosteroid-resistant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Effect of betamethasone on airway obstruction and bronchial response to salbutamol in prednisolone resistant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized Brown-Norway rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.6_PT_2.S125

10.1164/AJRCCM/152.6_PT_2.S125

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference